Munyori: Gregory Harris
Zuva Rekusika: 14 Kubvumbi 2021
Gadziridza Zuva: 18 Mbudzi 2024
Anonim
Mode of action of Saccharomyces boulardii CNCM I-745
Vhidhiyo: Mode of action of Saccharomyces boulardii CNCM I-745

Zvemukati

Saccharomyces boulardii ndiyo mbiriso. Yakanga yambozivikanwa senge yakasarudzika mhando yembeu. Ikozvino zvinofungidzirwa kuti idambudziko reSaccharomyces cerevisiae. Asi Saccharomyces boulardii yakasiyana nemamwe maratidziro eSaccharomyces cerevisiae anowanzozivikanwa sembiriso yemubiki uye mbiriso yemubiki. Saccharomyces boulardii inoshandiswa semushonga.

Saccharomyces boulardii inowanzo shandiswa pakurapa nekudzivirira manyoka, kusanganisira mhando dzinotapukira senge rotaviral manyoka muvana. Iine humwe humbowo hwekushandisa kune mamwe marudzi emanyoka, acne, uye chirwere chekugaya chirwere chinogona kutungamira kune maronda.

Coronavirus chirwere 2019 (COVID-19): Hapana humbowo hwakanaka hwekutsigira uchishandisa Saccharomyces boulardii yeCOVID-19. Tevera sarudzo dzakanaka dzemararamiro uye nzira dzakadzivirirwa dzekudzivirira pachinzvimbo.

Natural Mishonga Inonzwisisika Dhatabhesi zvinowanisa kushanda kunoenderana neuchapupu hwesainzi zvinoenderana nezviyero zvinotevera: Zvinobudirira, Zvichida Zvinobudirira, Zvichida Zvinobudirira, Zvichida Hazvishande, Zvichida Hazvibatsiri, Hazvibatsiri, uye Huchakwana Huchapupu hweKutara.

Iko kushanda ratings kwe ZVITSAUKO BOULARDII zvinotevera:


Zvichida zvinoshanda ...

  • Manyoka. Tsvagiridzo inoratidza kuti kupa Saccharomyces boulardii kuvana vane chirwere chemanyoka kunogona kudzora kuti zvinogara sei kusvika kuzuva rimwe. Asi Saccharomyces boulardii inoita kunge isingashande kupfuura mishonga yakajairika yemanyoka, senge loperamide (Imodium).
  • Manyoka anokonzerwa ne rotavirus. Kupa Saccharomyces boulardii kuvacheche uye vana vane manyoka anokonzerwa ne rotavirus kunogona kudzora kuti manyoka anogara kwenguva yakareba sei nezuva rimwe chete.

Zvichida inoshanda kune ...

  • Acne. Kutsvagurudza kunoratidza kuti kutora Saccharomyces boulardii nemuromo kunobatsira kugadzirisa chitarisiko chemakona.
  • Dhairrhea muvanhu vanotora mishonga inorwisa mabhakitiriya.. Yakawanda tsvagiridzo inoratidza kuti Saccharomyces boulardii inogona kubatsira kudzivirira manyoka muvanhu vakuru nevana vari kurapwa nemishonga inorwisa mabhakitiriya. Kune vese 9-13 varwere vanorapwa neSaccharomyces boulardii panguva yekurapwa nemishonga inorwisa mabhakitiriya, munhu mumwe mudiki anozoita manyoka ane hukama nemishonga inorwisa mabhakitiriya.
  • Kutapukirwa kwenzvimbo yemudumbu nemabhakitiriya anonzi Clostridium difficile. Kutora Saccharomyces boulardii pamwe nemishonga inorwisa mabhakitiriya zvinoita kunge kunobatsira kudzivirira chirwere cheClostridium difficile-chakabatana kubva mukudzokororwa muvanhu vane nhoroondo yekudzokerazve. Kutora Saccharomyces boulardii pamwe nemishonga inorwisa mabhakitiriya zvakare zvinoita sekubatsira kudzivirira episodes dzekutanga dzeClostridium difficile-inosangana nemanyoka. Asi nyanzvi hadzisi kukurudzira kushandisa Saccharomyces yekudzivirira episodes dzekutanga.
  • Utachiona hwehutachiona hunogona kutungamira kune maronda (Helicobacter pylori kana H. pylori). Kutora Saccharomyces boulardii nemuromo pamwe neyakajairwa H. pylori kurapwa kunobatsira kurapa hutachiona uhu. Vanenge vanhu gumi nevaviri vanoda kurapwa neSaccharomyces boulardii yekuwedzera kune mumwe murwere angadai akaramba aine hutachiona kuti arapwe. Kutora Saccharomyces boulardii zvakare kunobatsira kudzivirira mhedzisiro senge dhayeti uye kusvotwa kunoitika neyakajairwa kurapwa kwaH. Izvi zvinogona kubatsira vanhu kupedzisa kwavo kwakajairwa kurapwa kwaH. Pylori.
  • Manyoka muvanhu vane HIV / AIDS. Kutora Saccharomyces boulardii nemuromo zvinoita sekuderedza manyoka ane chekuita neHIV.
  • Chirwere chakakomba chemukati muvacheche vasati vasvika (necrotizing enterocolitis kana NEC). Yakawanda tsvagiridzo inoratidza kuti kupa Saccharomyces boulardii kutora preterm vacheche kunodzivirira NEC.
  • Manyoka evashanyi. Kutora Saccharomyces boulardii nemuromo zvinoita sekudzivirira manyoka evafambi.

Pamwe hazvibatsiri ...

  • Utachiona hweropa (sepsis). Tsvagiridzo inoratidza kuti kupa Saccharomyces boulardii kutangira vacheche hakudziviriri sepsis.

Husingakwani humbowo hwekuyera kushanda kwe ...

  • Utachiona hwematumbo hunokonzera manyoka (cholera). Saccharomyces boulardii inoita kunge isiri kugadzirisa cholera zviratidzo, kunyangwe painopihwa neyakajairika kurapwa.
  • Ndangariro uye hunyanzvi hwekufunga (kugona kuita basa). Kutsvagurudza kwekutanga kunoratidza kuti kutora Saccharomyces boulardii hakubatsire vadzidzi kuita zvirinani pabvunzo kana kudzikisira kushushikana kwavo.
  • Rudzi rwehutachiona hwechirwere (chirwere cheCrohn). Kutora Saccharomyces boulardii inoita kunge inoderedza huwandu hwematumbo muvanhu vane Crohn chirwere. Ongororo yekutanga inoratidzawo kuti kutora Saccharomyces boulardii pamwe chete nemesalamine kunogona kubatsira vanhu vane chirwere cheCrohn kugara mukuregererwa kwenguva refu. Asi kutora Saccharomyces boulardii chete hakuite kunge kunobatsira vanhu vane Crohn chirwere kugara mukuregererwa kwenguva refu.
  • Cystic fibrosis. Kutsvagurudza kwekutanga kunoratidza kuti kutora Saccharomyces boulardii nemuromo hakuderedze hutachiona hwembiriso munzira yekugaya yevanhu vane cystic fibrosis.
  • Kutadza kwemoyo. Kutsvagurudza kwekutanga kunoratidza kuti kutora Saccharomyces boulardii kunogona kuvandudza moyo kushanda mukati mevanhu vane moyo kutadza.
  • Cholesterol yakakwira. Kutsvagurudza kwekutanga kunoratidza kuti Saccharomyces boulardii inoita kunge isingakanganise huwandu hwecholesterol.
  • Kuvhiringidzika-kwenguva refu kwematumbo makuru anokonzera kurwadziwa kwemudumbu (anogumbura ura syndrome kana IBS). Kutsvagurudza kunoratidza kuti kutora Saccharomyces boulardii kunovandudza hupenyu hwevanhu mune vanhu vane manyoka-akanyanya kana akavhenganiswa-mhando IBS. Asi Saccharomyces boulardii inoita kunge isiri kugadzirisa zviratidzo zveBS zvakanyanya sekurwadziwa mudumbu, kukurumidza, kana kuzvimba.
  • Kubatwa kwematumbo nezvipembenene. Kutsvagurudza kwekutanga kunoratidza kuti kutora Saccharomyces boulardii nemuromo pamwe nemishonga inorwisa mabhakitiriya kunoderedza manyoka uye kurwadziwa nemudumbu kune vanhu vane hutachiona hwe amoeba.
  • Kupenya kweganda mucheche (neonatal jaundice). Vamwe vacheche vanokudziridza jaundice mushure mekuberekwa nekuda kwemazinga epamusoro ebilirubin. Kupa Saccharomyces boulardii kumisikidza vacheche kunogona kudzivirira jaundice uye kudzikisira kudiwa kwefototherapy mune vashoma veava vacheche. Asi hazvizivikanwe kana Saccharomyces boulardii inoderedza njodzi yejaundice mune vari panjodzi vacheche. Kupa Saccharomyces boulardii kuvacheche pamwe nephototherapy hakudzikise huwandu hwebirirubin zvirinani pane phototherapy chete.
  • Vacheche vanozvarwa vairema isingasviki 2500 gramu (mashanu mapaundi, 8 maiza). Kupa Saccharomyces boulardii yekuwedzera mushure mekuzvarwa inoita kunge inovandudza huremu nekupa kudya muvacheche vasati vatanga vane huremu hwekuzvarwa.
  • Kuwedzera kukura kwebhakitiriya mumatumbo madiki. Kutsvagurudza kwekutanga kunoratidza kuti kuwedzera Saccharomyces boulardii pakurapa nemishonga inorwisa mabhakitiriya kunoderedza hutachiona kukura mumatumbu zvirinani pane maantibiotiki ega.
  • Rudzi rwekuputira ura chirwere (ulcerative colitis). Kutsvagurudza kwekutanga kunoratidza kuti kuwedzera Saccharomyces boulardii kune yakajairwa mesalamine kurapa kunogona kudzikisa zviratidzo kune vanhu vane hunyoro-kusvika-kuenzanisa ulcerative colitis.
  • Maronda egungwa.
  • Fivha mhoni.
  • Mikoko.
  • Lactose kusagadzikana.
  • Chirwere cheLyme.
  • Tsvina kusuruvara kunokonzerwa nekurovedza muviri.
  • Urinary turakiti hutachiona (UTIs).
  • Mbiriso zvirwere.
  • Mamwe mamiriro.
Humwe humbowo hunodiwa kuyera Saccharomyces boulardii kune izvi zvinoshandiswa.

Saccharomyces boulardii inonzi "probiotic," inhengo ine hushamwari iyo inobatsira kurwisa zvipuka-zvinokonzeresa zvirwere mumatumbu zvakaita sebhakitiriya nembiriso.

Kana ikatorwa nemuromo: Saccharomyces boulardii iri ZVIMWE ZVAKANAKA kune vanhu vakuru vazhinji pavanotorwa nemuromo kwemwedzi inosvika gumi nemashanu. Inogona kukonzera gasi mune vamwe vanhu. Kazhinji, zvinogona kukonzera hutachiona hunopararira kuburikidza neropa kuenda kune muviri wese (fungemia).

Special matanho & yambiro:

Kubata uye kuyamwisa: Iko hakuna kukwana kwakaringana ruzivo rwekuziva kana Saccharomyces boulardii yakachengeteka kushandisa kana uine pamuviri kana kuyamwisa. Gara padivi rakachengeteka uye dzivisa kushandisa.

Vana: Saccharomyces boulardii iri ZVINOKOSHA KUNENGE yevana kana ikatorwa nemuromo zvakakodzera. Nekudaro, manyoka muvana anofanirwa kuongororwa nenyanzvi yezvehutano vasati vashandisa Saccharomyces boulardii.

Vakwegura: Vakwegura vanogona kunge vaine njodzi yekuwedzera hutachiona kana vachitora Saccharomyces boulardii. Gara padivi rakachengeteka uye dzivisa kushandisa.

Dziviriro yezvirwere mumuviri: Pane kumwe kunetsekana kuti kutora Saccharomyces boulardii kunogona kukonzera fungemia, ndiko kuvapo kwembiriso muropa. Iyo chaiyo nhamba yezviitiko zveSaccharomyces boulardii-zvine hukama fungemia yakaoma kuziva. Zvisinei, njodzi inoratidzika kunge yakanyanya kukura kune vanhu vanorwara zvakanyanya kana avo vakaneta immune system. Kunyanya, vanhu vane catheters, avo vanogamuchira chubhu yekupa, uye avo vari kurapwa nemazhinji maantibayoti kana maantibayoti ayo anoshanda pazvirwere zvakasiyana siyana zvinoita kunge vari panjodzi huru. Muzviitiko zvakawanda, fungemia yakakonzerwa nekushatiswa kwekateti nemhepo, nzvimbo dzezvakatipoteredza, kana maoko akashatiswa neSaccharomyces boulardii.

Mbiriso allergy: Vanhu vane mbiriso allergy vanogona kunge vari allergiki kune zvigadzirwa zvine Saccharomyces boulardii, uye vanokurudzirwa zvakanyanya kudzivirira izvo zvigadzirwa.

Zvishoma
Ngwarira nekubatanidzwa uku.
Mishonga yezvirwere zvefungal (Antifungals)
Saccharomyces boulardii chakuvhe. Mishonga yezvirwere zvefungus inobatsira kudzikisa fungus mukati nemumuviri. Kutora Saccharomyces boulardii nemishonga yehutachiona hutachiona kunogona kudzikamisa kushanda kweSaccharomyces boulardii.
Mimwe mishonga yehutachiona hutachiona inosanganisira fluconazole (Diflucan), caspofungin (Cancidas), itraconazole (Sporanox) amphotericin (Ambisome), nevamwe.
Iko hakuna kuzivikanwa kwekudyidzana nemishonga uye zvinowedzera.
Iko hakuna kuzivikanwa kudyidzana nezvikafu.
Iyi inotevera doses yakadzidzwa mukutsvaga kwesainzi:

VAKURU

Nemuromo:
  • Nezve diarrhea mune vanhu vanotora maantibayoti: 250-500 mg yeSaccharomyces boulardii inotorwa 2-4 nguva zuva nezuva kweanosvika mavhiki maviri inowanzo shandiswa. Muzviitiko zvakawanda, madosi ezuva nezuva haapfuure 1000 mg zuva nezuva.
  • Nehutachiona hwegwara remudumbu nemabhakitiriya anonzi Clostridium difficile: Yekudzivirira kudzokororazve, 500 mg yeSaccharomyces boulardii kaviri zuva nezuva kwemavhiki mana pamwe nemushonga unorwisa mabhakitiriya wakashandiswa.
  • Yechirwere chekugaya chirwere chinogona kutungamira kune maronda (Helicobacter pylori kana H. pylori): 500-1000 mg yeSaccharomyces boulardii zuva rega rega kwevhiki 1-4 inowanzoshandiswa.
  • Yezve manyoka muvanhu vane HIV / AIDS: 3 magiramu eSaccharomyces boulardii mazuva ese.
  • Zvemanyoka evafambi: 250-1000 mg yeSaccharomyces boulardii zuva nezuva kwemwedzi mumwe.
VANA

Nemuromo:
  • Nezve diarrhea mune vanhu vanotora maantibayoti: 250 mg yeSaccharomyces boulardii kamwe kana kaviri pazuva kweiyo nguva yemishonga inorwisa mabhakitiriya yashandiswa.
  • Zvemanyoka: Pakurapa manyoka akanyanya, 250 mg yeSaccharomyces boulardii kamwe kana kaviri zuva nezuva kana gumi emabhiriyoni-ekuumba mayunitsi kamwe zuva nezuva kwemazuva mashanu akashandiswa. Pakurapa manyoka anoramba aripo, 1750 bhiriyoni kusvika 175 matiririyoni emakoni-ekuumba zvikamu zveSaccharomyces boulardii kaviri zuva nezuva kwemazuva mashanu zvakashandiswa. Yekudzivirira manyoka muvanhu vanogamuchira chubhu feedings, 500 mg yeSaccharomyces boulardii kanokwana kana zuva nezuva kwave kushandiswa.
  • Zvemanyoka zvinokonzerwa ne rotavirus: 200-250 mg yeSaccharomyces boulardii kaviri zuva nezuva kwemazuva mashanu akashandiswa.
  • Yechirwere chakakomba chemuura mune vacheche vasati vasvika (necrotizing enterocolitis kana NEC): 100-200 mg / kg Saccharomyces boulardii mazuva ese, kutanga vhiki rekutanga mushure mekuberekwa.
Probiotic, Probiotique, Saccharomyces, Saccharomyces Boulardii CNCM I-745, Saccharomyces Boulardii HANSEN CBS 5926, Saccharomyces Boulardii Lyo CNCM I-745, Saccharomyces Boulardius, Saccharomyces Cerevisiae Boulardii, Saccharomyces (Saccharomyces) Cerevisiae HANSEN CBS 5926, Saccharomyces cerevisiae var boulardii, S. Boulardii, SCB.

Kuti udzidze zvakawanda nezvekuti chinyorwa ichi chakanyorwa sei, ndapota ona iyo Natural Mishonga Inonzwisisika Dhatabhesi nzira.


  1. Florez ID, Veroniki AA, Al Khalifah R, et al. Kuenzanisa kushanda pamwe nekuchengetedzeka kwekupindira kwechirwere chakanyanya uye gastroenteritis muvana: Kuongorora kwakarongeka uye network meta-ongororo. PLoS Imwe. 2018; 13: e0207701. Wona zvisingabvumirwe.
  2. Harnett JE, Pyne DB, McKune AJ, Penm J, Pumpa KL. Probiotic yekuwedzera inokonzeresa shanduko yakanaka musuru kusuruvara uye hunhu hwekurara muvatambi ve rugby. J Sci Med Sport. 2020: S1440-244030737-4. Wona zvisingabvumirwe.
  3. Gao X, Wang Y, Shi L, Feng W, Yi K. Mhedzisiro uye chengetedzo yeSaccharomyces boulardii yeNeonatal necrotizing enterocolitis mu pre-term vacheche: Kuongorora kwakarongeka uye meta-ongororo. J Trop Pediatr. 2020: fmaa022. Wona zvisingabvumirwe.
  4. Mourey F, Sureja V, Kheni D, et al. Iyo multicenter, yakasarudzika, yakapofumara-yakapofumara, inochengetwa-inodzorwa-pabhodhi kuyedzwa kweSaccharomyces boulardii muvacheche uye vana vane chirwere chakanyanya. Pediatr Infect Dis J. 2020; 39: e347-e351. Wona zvisingabvumirwe.
  5. Karbownik MS, Kr & eogon; czy & nacute; ska J, Kwarta P, et al. Mhedzisiro yekuwedzera neSaccharomyces boulardii pakudzidza kwekuongorora mashandiro uye kushushikana kwakanangana nevadzidzi vane hutano vekurapa: Riyero yakasarudzika, yakapofomara-bofu, inodzorwa ne placebo. Nutrients. 2020; 12: 1469. Wona zvisingabvumirwe.
  6. Zhou BG, Chen LX, Li B, Wan LY, Ai YW. Saccharomyces boulardii seAdjuvant Therapy yeHelicobacter pylori eradication: Kuongorora kwakarongeka uye meta-ongororo pamwe nekuyedza kwakateedzana kuongororwa. Helicobacter. 2019; 24: e12651. Wona zvisingabvumirwe.
  7. Szajewska H, ​​Kolodziej M, Zalewski BM. Kuongorora kwakarongeka nemeta-ongororo: Saccharomyces boulardii yekurapa acute gastroenteritis muvana-2020 yekuvandudza. Zvidimbu Pharmacol Ther. Tarisa zvinyorwa.
  8. Seddik H, Boutallaka H, ​​Elkoti I, et al. Saccharomyces boulardii CNCM I-745 pamwe neakateedzana kurapwa kweHelicobacter pylori hutachiona: yakasarudzika, yakavhurika-yekuyedza muyedzo. Eur J Kliniki Pharmacol. 2019; 75: 639-645. Wona zvisingabvumirwe.
  9. García-Collinot G, Madrigal-Santillán EO, Martínez-Bencomo MA, et al. Kubudirira kweSaccharomyces boulardii uye Metronidazole yeDiki Intestinal Bhakitiriya Kukura muSystemic Sclerosis .Dig Dis Sci. 2019. Wona zvisingabvumirwe.
  10. McDonald LC, Gerding DN, Johnson S, et al .; Zvirwere Zvinotapukira Sangano reAmerica. Clinical tsika nhungamiro yeClostridium difficile hutachiona muvakuru nevana: 2017 inogadzirisirwa neInfectious Diseases Society yeAmerica (IDSA) uye Sosaiti yeHutano Hutano Epidemiology yeAmerica (SHEA) Clinical Inotapukira Zvirwere 2018; 66: e1-e48.
  11. Xu L, Wang Y, Wang Y, et al. Chiyedzo chakapofumadzwa-chakapetwa chakasarudzika pakukura uye kudyira kushivirira neSaccharomyces boulardii CNCM I-745 mufomula-yakadyiwa preterm vacheche. J Pediatr (Rio J). 2016; 92: 296-301. Wona zvisingabvumirwe.
  12. Sheele J, Cartowski J, Dart A, et al. Saccharomyces boulardii uye bismuth subsalicylate senzira dzemitengo yakaderera kudzikisa nguva uye kuomarara kwekorera. Pathog Glob Hutano. 2015; 109: 275-82. Wona zvisingabvumirwe.
  13. Ryan JJ, Hanes DA, Schafer MB, Mikolai J, Zwickey H. Mhedzisiro yeProbiotic Saccharomyces boulardii paCholesterol uye Lipoprotein Particles muHypercholesterolemic Vakuru: Imwe-Ruoko, Yakavhurika-Label Pilot Study. J Zvimwe Kuzadzisa Med. 2015; 21: 288-93. Wona zvisingabvumirwe.
  14. Flatley EA, Wilde AM, Nailor MD. Saccharomyces boulardii yekudzivirira chipatara chinotanga Clostridium difficile hutachiona. J Gastrointestin Chiropa Dis. 2015; 24: 21-4. Wona zvisingabvumirwe.
  15. Ehrhardt S, Guo N, Hinz R, uye al. Saccharomyces boulardii Kudzivirira Antibiotic-Yakabatana Dhiarrhea: Randomized, Double-Masked, Placebo-Inodzorwa Trial. Vhura foramu Infect Dis. 2016; 3: ye011. Wona zvisingabvumirwe.
  16. Dinleyici EC, Kara A, Dalgic N, uye al. Saccharomyces boulardii CNCM I-745 inoderedza nguva yemanyoka, kureba kwekukurumidzira kuchengetwa uye kugara muchipatara muvana vane chirwere chakanyanya. Batsira Microbes. 2015; 6: 415-21. Wona zvisingabvumirwe.
  17. Dauby N. Njodzi dzeSaccharomyces boulardii-Iine MaProbiotic ekudzivirira kweClostridium difficile Infection muVakwegura. Gastroenterology. 2017; 153: 1450-1451. Wona zvisingabvumirwe.
  18. Cottrell J, Koenig K, Perfekt R, Hofmann R; Loperamide-Simethicone Acute Dhiarrhea Yekudzidza Chikwata. Kufananidza kweMhando mbiri dzeLoperamide-Simethicone uye Mbiriso yeProbiotic (Saccharomyces boulardii) Mukurapa kweAcute Dharare muVakuru: Randomized Non-inferiority Clinical Trial. Zvinodhaka R D. 2015; 15: 363-73. Wona zvisingabvumirwe.
  19. Costanza AC, Moscavitch SD, Faria Neto HC, Mesquita ET. Probiotic kurapa neSaccharomyces boulardii yevarwere vemwoyo vanokundikana. Int J Cardiol. 2015; 179: 348-50. Wona zvisingabvumirwe.
  20. Carstensen JW, Chehri M, Schønning K, uye al. Kushandiswa kweprophylactic Saccharomyces boulardii kudzivirira hutachiona hweClostridium difficile muzvipatara varwere: inodzorwa inotarisirwa yekupindira kudzidza. Eur J Clin Microbiol Inotadza Dis. 2018; 37: 1431-1439. Wona zvisingabvumirwe.
  21. Asmat S, Shaukat F, Asmat R, Bakhat HFSG, Asmat TM. Clinical Efficacy Kuenzanisa kweSaccharomyces Boulardii uye Lactic Acid seProbiotic muAcute Pediatric Dhiarhea. J Coll Chiremba Chiremba Pak. 2018; 28: 214-217. Wona zvisingabvumirwe.
  22. Remenova T, Morand O, Amato D, Chadha-Boreham H, Tsurutani S, Marquardt T. Kuedzwa kwakapofumadzwa, kurongedzwa, kurongedzwa kwepa placebo kuongorora mhedzisiro yeSaccharomyces boulardii pakubata kwemazamu, kuchengetedzeka, uye pharmacokinetics yemiglustat. Nherera J Rare Dis 2015; 10: 81. Wona zvisingabvumirwe.
  23. Suganthi V, Das AG. Basa reSaccharomyces boulardii mukuderedza kweanaonatal hyperbilirubinemia. J Clin Kuongorora Res 2016; 10: SC12-SC15. Wona zvisingabvumirwe.
  24. Riaz M, Alam S, Malik A, Ali SM. Kubudirira uye kuchengetedzeka kweSaccharomyces boulardii mune yakashata yemanyoka ehudiki: yakapofumara yakapofumara yakarongedzwa muyedzo. Indian J Pediatr 2012; 79: 478-82. Wona zvisingabvumirwe.
  25. - Corrêa NB, Penna FJ, Lima FM, Nicoli JR, Filho LA. Kurapa kwechirwere chakanyanya neSaccharomyces boulardii muvacheche. J Pediatr Gastroenterol Nutriti 2011; 53: 497-501. Wona zvisingabvumirwe.
  26. Cohen SH, Gerding DN, Johnson S, et al .; Sosaiti yehutano Hutano Epidemiology yeAmerica; Zvirwere Zvinotapukira Sangano reAmerica. Clinical tsika nhungamiro yeClostridium difficile hutachiona muvanhu vakuru: 2010 inogadzirisirwa nesangano rehutano hwehutachiona hweAmerica (SHEA) pamwe nehutachiona hutachiona nzanga yeAmerica (IDSA). Infect Kudzora Hosp Epidemiol 2010; 31: 431-55. Wona zvisingabvumirwe.
  27. Goldenberg JZ, Ma SS, Saxton JD, et al. Probiotics ekudzivirira Clostridium difficile-inosangana nemanyoka muvakuru nevana. Cochrane Dhatabhesi Syst Rev. 2013;: CD006095. Wona zvisingabvumirwe.
  28. Lau CS, Chamberlain RS. Probiotics anoshanda pakudzivirira Clostridium difficile-inosangana nemanyoka: kuongororwa kwakarongeka uye meta-ongororo. Int J Gen Med. 2016; 9: 27-37. Wona zvisingabvumirwe.
  29. Roy U, Jessani LG, Rudramurthy SM, et al. Mhosva nomwe dzeSaccharomyces fungaemia inoenderana nekushandiswa kwemaprobiotic. Mycoses 2017; 60: 375-380. Wona zvisingabvumirwe.
  30. Romanio MR, Coraine LA, Maielo VP, Abramczyc ML, Souza RL, Oliveira NF. Saccharomyces cerevisiae fungemia mune yevarwere murwere mushure mekurapwa nemaprobiotic. Rev Paul Pediatr 2017; 35: 361-4. Wona zvisingabvumirwe.
  31. Pozzoni P, Riva A, Bellatorre AG, et al. Saccharomyces boulardii yekudzivirira chirwere cheshuramatongo-chinosangana nemanyoka muvanhu vakuru vari muchipatara varwere: imwe-yepakati, yakasarudzika, yakapofumara-yakapofumara, inodzorwa ne placebo-inodzorwa. Am J Gastroenterol 2012; 107: 922-31. Wona zvisingabvumirwe.
  32. Martin IW, Tonner R, Trivedi J, et al. Saccharomyces boulardii probiotic-inosanganisirwa fungemia: kubvunza kuchengetedzwa kweiyi yekudzivirira probiotic yekushandisa. Ongorora Microbiol Infect Dis. 2017; 87: 286-8. Wona zvisingabvumirwe.
  33. Choi CH, Jo SY, Park HJ, Chang SK, Byeon JS, Myung SJ. Yakasarudzika, yakapofomara-bofu, inodzora-placebo-inodzorwa multicenter kuyedzwa kweSaccharomyces boulardii mune inogumbuka ura chirwere: maitiro pahunhu hwehupenyu. J Clin Gastroenterol. 2011; 45: 679-83. Wona zvisingabvumirwe.
  34. Atici S, Soysal A, Karadeniz Cerit K, uye al. Catheter-inoenderana neSaccharomyces cerevisiae Fungemia Ichitevera Saccharomyces boulardii Probiotic Kurapa: Mune mwana ari muchipatara chevanonyanya kurapwa uye kuongorora zvinyorwa. Med Mycol Nyaya Rep. 2017; 15: 33-35. Wona zvisingabvumirwe.
  35. Appel-da-Silva MC, Narvaez GA, Perez LRR, Drehmer L, Lewgoy J. Saccharomyces cerevisiae var. boulardii fungemia inotevera kurapwa kweprobiotic. Med Mycol Nyaya Rep. 2017; 18: 15-7. Wona zvisingabvumirwe.
  36. Chang HY, Chen JH, Chang JH, Lin HC, Lin CY, Peng CC. Multiple strains probiotic inoita kunge maprobioti anonyanya kushanda mukudzivirira kwecrotizing enterocolitis uye kufa: Anovandudzwa meta-ongororo. PLoS Imwe. 2017; 12: e0171579. Wona zvisingabvumirwe.
  37. Blaabjerg S, Artzi DM, Aabenhus R. Mapurobioti ekudzivirira kweAntibiotic-Yakabatana Dhiarrhea mune Vanorapa-Kuongorora Kwakarongeka uye Meta-Kuongorora. Mishonga inorwisa mabhakitiriya (Basel). 2017; 6. Wona zvisingabvumirwe.
  38. Al Faleh K, Anabrees J. Mapurobioti ekudzivirira necrotizing enterocolitis muvana vasati vatanga. Cochrane Database Syst Rev. 2014;: CD005496. Wona zvisingabvumirwe.
  39. Das S, Gupta PK, Das RR. Kubudirira uye Kuchengetedzwa kweSaccharomyces boulardii muAcute Rotavirus Dhairrhea: Yakapofumadzwa Ruviri Randomized Kudzora Muedzo kubva kuNyika Iri Kukura. J Trop Pediatr. 2016; 62: 464-470. Wona zvisingabvumirwe.
  40. Goldenberg JZ, Lytvyn L, Steurich J, Parkin P, Mahant S, Johnston BC. Probiotic ekudzivirira kwehutachiona hwehutachiona-hunosangana nemanyoka. Cochrane Dhatabhesi Syst Rev. 2015;: CD004827. Wona zvisingabvumirwe.
  41. Feizizadeh S, Salehi-Abargouei A, Akbari V. Kubudirira uye chengetedzo yeSaccharomyces boulardii yechirwere chakanyanya. Pediatrics. 2014; 134: e176-191. Wona zvisingabvumirwe.
  42. Szajewska H, ​​Horvath A, Kolodziej M. Kuongorora kwakarongeka nemeta-ongororo: Saccharomyces boulardii kuwedzera uye kupedza hutachiona hweHelicobacter pylori. Zvidimbu Pharmacol Ther. 2015; 41: 1237-1245. Wona zvisingabvumirwe.
  43. Szajewska H, ​​Kolodziej M. Kuongorora kwakarongeka nemeta-ongororo: Saccharomyces boulardii mukudzivirira kwemishonga inorwisa mabhakitiriya. Zvidimbu Pharmacol Ther. 2015; 42: 793-801. Wona zvisingabvumirwe.
  44. Ellouze O, Berthoud V, Mervant M, Parthiot JP, Girard C. Septic kuvhunduka nekuda kweSacccaromyces boulardii. Med Mal Inotapura. 2016; 46: 104-105. Wona zvisingabvumirwe.
  45. Bafutto M, et al. Kurapa kwemanyoka-kwakanyanya kunotsamwisa bowel syndrome ine mesalamine uye / kana Saccharomyces boulardii. Arq Gastroenterol. 2013; 50: 304-309. Wona zvisingabvumirwe.
  46. Bourreille A, et al. Saccharomyces boulardii haidziviriri kudzokazve kwechirwere cheCrohn. Kliniki Gastroenterol Hepatol. 2013; 11: 982-987.
  47. Serce O, Gursoy T, Ovali F, Karatekin G. Mhedzisiro yeSaccaromyces boulardii pane neonatal hyperbilirubinemia: ongororo yakarongedzwa. Ndiri J Perinatol. 2015; 30: 137-142. Wona zvisingabvumirwe.
  48. Videlock EJ, Cremonini F. Meta-ongororo: maprobiotic muhutachiona-hwakabatana manyoka. Zvidimbu Pharmacol Ther. 2012; 35: 1355-69. Wona zvisingabvumirwe.
  49. Hempel S, Newberry SJ, Maher AR, Wang Z, Miles JN, Shanman R, Johnsen B, Shekelle PG. Probiotic ekudzivirira uye kurapwa kwehutachiona-inosanganisirwa diarrhea: ongororo yakarongeka uye meta-ongororo. JAMA. 2012 9; 307: 1959-69. Wona zvisingabvumirwe.
  50. Elmer GW, Moyer KA, Vega R, uye et al. Kuongororwa kweSaccharomyces boulardii yevarwere vane chirwere cheshuramatongo chisingaperi chine chekuita neHIV uye nevanozvipira vane hutano vanowana mishonga yekudzivirira. Microecology Ther 1995; 25: 23-31.
  51. Potts L, Lewis SJ, naBarry R. Randomized double blind placebo inodzora kudzidza kugona kweSaccharomyces boulardii kudzivirira manyoka ane hukama nemishonga inorwisa mabhakitiriya [abstract]. Gut 1996; 38 (suppl 1): A61.
  52. Bleichner G uye Blehaut H. Saccharomyces boulardii inodzivirira manyoka muvane chirwere chakakomba vanorwara nechubhu. Iyo multicenter, yakasarudzika, yakapofumadza-bofu-inodzora placebo-inodzorwa muedzo [abstract] Kiriniki Nutriti 1994; 13 Suppl 1:10.
  53. Maupas JL, Champemont P, naDelforge M. [Kurapa kweinoshatirisa ura chirwere neSaccharomyces boulardii - yakapofomara-bofu, inodzora placebo inodzorwa]. Médicine et Chirurgie Digestives 1983; 12: 77-79.
  54. Saint-Marc T, Blehaut H, Musial C, uye et al. [Manyoka ane chekuita neAIDS: kuyedzwa kwakapofumara-kaviri kweSaccharomyces boulardii]. Semaine Des Hopitaux 1995; 71 (23-24): 735-741.
  55. McFarland LV, Surawicz C, Greenberg R, uye et al. Saccharomyces boulardii uye yakakwira dhosi vancomycin inobata yakajairika Clostridium difficile chirwere [abstract]. Am J Gastroenterol 1998; 93: 1694.
  56. Chouraqui JP, Dietsch J, Musial C, uye et al. Saccharomyces boulardii (SB) mune manejimendi yemucheche wemanyoka: yekaviri-bofu-placebo inodzorwa kudzidza [abstract]. J Pediatr Gastroenterol Nutriti 1995; 20: 463.
  57. Cetina-Sauri G uye Basto GS. Evaluacion terapeutica de Saccharomyces boulardii en ninos con diarrea aguda. Tribuna Med 1989; 56: 111-115.
  58. Adam J, Barret C, Barret-Bellet A, uye et al. Essais cliniques controles en kaviri insu de l'Ultra-Levure Lyophilisee. Etude multicentrique par 25 medecins de 388 cas. Gaz Med Fr 1977; 84: 2072-2078.
  59. McFarland LV, SurawiczCM, Elmer GW, uye et al. Multivariate ongororo yeiyo kiriniki inoshanda yeiyo biotherapeutic mumiririri, Saccharomyces boulardii yekudzivirira chirwere chinorwisa mabhakitiriya [chinobatanidza]. Am J Epidemiol 1993; 138: 649.
  60. Saint-Marc T, Rossello-Prats L, uye Touraine JL. [Kubudirira kweSaccharomyces boulardii mukutarisira chirwere cheAIDS]. Ann Med Interne (Paris) 1991; 142: 64-65.
  61. Kirchhelle, A., Fruhwein, N., naToburen, D. [Kurapa kwemanyoka anoramba aripo naS S. boulardii mukufambisa vanodzoka. Mhedzisiro yeanotarisira kudzidza]. Fortschr Med 4-20-1996; 114: 136-140. Wona zvisingabvumirwe.
  62. Akazvarwa, P., Lersch, C., Zimmerhackl, B., uye Classen, M. [Iyo Saccharomyces boulardii kurapa kwemanyoka ane hukama neHIV]. Dtsch Med Wochenschr 5-21-1993; 118: 765. Wona zvisingabvumirwe.
  63. Kollaritsch, H., Holst, H., Grobara, P., naWiedermann, G. [Kudzivirira manyoka emufambi neSaccharomyces boulardii. Mhedzisiro ye placebo inodzorwa kaviri-bofu kudzidza]. Fortschr.Med 3-30-1993; 111: 152-156. Wona zvisingabvumirwe.
  64. Tempe, J. D., Steidel, A. L., Blehaut, H., Hasselmann, M., Lutun, P., naMaurier, F. [Kudzivirira manyoka achipa Saccharomyces boulardii panguva yekuenderera mberi kwekudya]. Sem.Hop. 5-5-1983; 59: 1409-1412. Wona zvisingabvumirwe.
  65. Chapoy, P. [Kurapa kwechirwere chemanyoka chakakomba: kudzora kutongwa kweSaccharomyces boulardii]. Ann Pediatr. (Paris) 1985; 32: 561-563. Wona zvisingabvumirwe.
  66. Kimmey, M. B., Elmer, G. W., Surawicz, C. M., naMcFarland, L. V. Kudzivirira kumwezve kudzokororwa kweClostridium difficile colitis ine Saccharomyces boulardii. Chera .Dis Sci 1990; 35: 897-901. Wona zvisingabvumirwe.
  67. Saint-Marc, T., Rossello-Prats, L., naTouraine, J. L. [Kubudirira kweSaccharomyces boulardii mukurapa manyoka muAIDS]. Ann Med Interne (Paris) 1991; 142: 64-65. Wona zvisingabvumirwe.
  68. Duman, DG, Bor, S., Ozutemiz, O., Sahin, T., Oguz, D., Istan, F., Vural, T., Sandkci, M., Isksal, F., Simsek, ini, Soyturk. , M., Arslan, S., Sivri, B., Soykan, I., Temizkan, A., Bessk, F., Kaymakoglu, S., uye Kalayc, C. Kubudirira uye kuchengeteka kweSaccharomyces boulardii mukudzivirira mishonga inorwisa mabhakitiriya- inosangana nemanyoka nekuda kweHelicobacterpylori kupedza. Eur J Gastroenterol, hepatol. 2005; 17: 1357-1361. Wona zvisingabvumirwe.
  69. Surawicz, C. M. Kurapa kweanowanzoitika Clostridium difficile-inosanganisirwa chirwere. Nat Clin Kudzidzira. Gastroenterol, hepatol. 2004; 1: 32-38. Wona zvisingabvumirwe.
  70. Kurugol, Z. uye Koturoglu, G. Mhedzisiro yeSaccharomyces boulardii muvana vane chirwere chakanyanya. Acta Paediatr. 2005; 94: 44-47. Wona zvisingabvumirwe.
  71. Kotowska, M., Albrecht, P., uye Szajewska, H. Saccharomyces boulardii mukudzivirira chirwere chinorwisa mabhakitiriya muvana. Zvidimbu.Pharmacol.Ther. 3-1-2005; 21: 583-590. Wona zvisingabvumirwe.
  72. Cherifi, S., Robberecht, J., uye Miendje, Y. Saccharomyces cerevisiae fungemia mune akwegura murwere ane Clostridium difficile colitis. Acta Clin Belg. 2004; 59: 223-224. Wona zvisingabvumirwe.
  73. Erdeve, O., Tiras, U., naDallar, Y. Iyo probiotic mhedzisiro yeSaccharomyces boulardii muboka rezera revana. J Trop Mudzidzisi. 2004; 50: 234-236. Wona zvisingabvumirwe.
  74. Costalos, C., Skouteri, V., Gounaris, A., Sevastiadou, S., Triandafilidou, A., Ekonomidou, C., Kontaxaki, F., naPetrochilou, V. Kudya kwevana vasati vasvika ne Saccharomyces boulardii. Pakutanga Hum. 2003; 74: 89-96. Wona zvisingabvumirwe.
  75. Gaon, D., Garcia, H., Nguva yechando, L., Rodriguez, N., Quintas, R., Gonzalez, S. N., naOliver, G. Mhedzisiro yematambudziko eLactobacillus uye Saccharomyces boulardii pakuramba kuri kuita manyoka muvana. Medicina (B Aires) 2003; 63: 293-298. Wona zvisingabvumirwe.
  76. Mansour-Ghanaei, F., Dehbashi, N., Yazdanparast, K., naShafaghi, A. Kubudirira kwesaccharomyces boulardii nemishonga inorwisa mabhakitiriya muacute amoebiasis. Nyika J Gastroenterol. 2003; 9: 1832-1833. Wona zvisingabvumirwe.
  77. Riquelme, A.J, Calvo, M.A, Guzman, A.M., Depix, M. S., Garcia, P., Perez, C., Arrese, M., naLabarca, J. A. Saccharomyces cerevisiae fungemia mushure mekurapwa kweSaccharomyces boulardii muvarwere vasina kugunun'una. J Kliniki Gastroenterol. 2003; 36: 41-43. Wona zvisingabvumirwe.
  78. Cremonini, F., Di Caro, S., Santarelli, L., Gabrielli, M., Candelli, M., Nista, EC, Lupascu, A., Gasbarrini, G., uye Gasbarrini, A. Mapurobioti anorwisa mabhakitiriya manyoka. Chera.River Dis. 2002; 34 Suppl 2: S78-S80. Wona zvisingabvumirwe.
  79. Lherm, T., Monet, C., Nougiere, B., Soulier, M., Larbi, D., Le Gall, C., Caen, D., naMalbrunot, C. Mhosva nomwe dzefungemia neSaccharomyces boulardii zvakanyanya varwere vanorwara. Kuchengetedza Kwakasimba Med 2002; 28: 797-801. Wona zvisingabvumirwe.
  80. Tasteyre, A., Barc, M. C., Karjalainen, T., Bourlioux, P., naCollignon, A. Kuvharirwa kwe in vitro cell kuomerera kweClostridium difficile neSaccharomyces boulardii. Microb.Pathog. 2002; 32: 219-225. Wona zvisingabvumirwe.
  81. Shanahan, F. Probiotic mune chinopisa chirwere chemuviri. Gut 2001; 48: 609. Wona zvisingabvumirwe.
  82. Surawicz, CM, McFarland, LV, Greenberg, RN, Rubin, M., Fekety, R., Mulligan, ME, Garcia, RJ, Brandmarker, S., Bowen, K., Borjal, D., uye Elmer, GW The tsvaga kurapwa kuri nani kwechirwere chinodzokororwa cheClostridium difficile: kushandiswa kwepamusoro-soro vancomycin inosanganiswa neSaccharomyces boulardii. Kliniki.Infect.Dis. 2000; 31: 1012-1017. Wona zvisingabvumirwe.
  83. Johnston BC, Ma SSY, Goldenberg JZ, et al. MaProbiotic ekudzivirira eCrostridium difficile-inosangana nemanyoka. Ann Mukati Med 2012; 157: 878-8. Wona zvisingabvumirwe.
  84. Munoz P, Bouza E, Cuenca-Estrella M, et al. Saccharomyces cerevisiae fungemia: chirwere chinotapukira chiri kubuda. Clin Infect Dis 2005; 40: 1625-34. Wona zvisingabvumirwe.
  85. Szajewska H, ​​Mrukowicz J. Meta-ongororo: isina-pathogenic mbiriso Saccharomyces boulardii mukudzivirira chirwere chinorwisa mabhakitiriya. Chidimbu Pharmacol Ther 2005; 22: 365-72. Wona zvisingabvumirwe.
  86. Unogona M, Besirbellioglu BA, Avci IY, et al. Prophylactic Saccharomyces boulardii mukudzivirira chirwere chinorwisa mabhakitiriya: Anotarisirwa kudzidza. Med Sci Monit 2006; 12: PI19-22. Wona zvisingabvumirwe.
  87. Guslandi M, Giollo P, Testoni PA. Muedzo wekutyaira weSaccharomyces boulardii mu ulcerative colitis. Eur J Gastroenterol Hepatol 2003; 15: 697-8. Wona zvisingabvumirwe.
  88. Guslandi M, Mezzi G, Sorghi M, Testoni PA. Saccharomyces boulardii mukuchengetedza kurapwa kwechirwere cheCrohn. Kuchera Dis Sci 2000; 45: 1462-4. Wona zvisingabvumirwe.
  89. McFarland LV. Meta-ongororo yemaprobiotic ekudzivirira maantibiotic anosangana nemanyoka uye kurapwa kweClostridium difficile chirwere. Am J Gastroenterol 2006; 101: 812-22. Wona zvisingabvumirwe.
  90. Marteau P, Seksik P. Kutsungirira kwemaprobiotic uye prebiotic. J Clin Gastroenterol 2004; 38: S67-9. Wona zvisingabvumirwe.
  91. Borriello SP, Nyundo WP, Holzapfel W, et al. Kuchengetedzwa kwemapurobioti ane lactobacilli kana bifidobacteria. Clin Infect Dis 2003; 36: 775-80. Wona zvisingabvumirwe.
  92. Cremonini F, Di Caro S, Covino M, uye al. Mhedzisiro yemagadzirirwo akasiyana eprobiotic pane anti-helicobacter pylori yekurapa-ane chekuita nemhedzisiro mhedzisiro: boka rakafanana, katatu bofu, placebo-inodzorwa kudzidza. Am J Gastroenterol 2002; 97: 2744-9. Wona zvisingabvumirwe.
  93. D'Souza AL, Rajkumar C, Cooke J, Bulpitt CJ. Probiotic mukudzivirira mishonga inorwisa mabhakitiriya inosangana nemanyoka: meta-ongororo. BMJ 2002; 324: 1361. Wona zvisingabvumirwe.
  94. Muller J, Remus N, Anokuvadza KH. Mycoserological kudzidza kwekurapwa kwevana cystic fibrosis varwere vane Saccharomyces boulardii (Saccharomyces cerevisiae Hansen CBS 5926). Mycoses 1995; 38: 119-23. Wona zvisingabvumirwe.
  95. Plein K. Z Gastroenterol 1993; 31: 129-34. Wona zvisingabvumirwe.
  96. Hennequin C, Thierry A, Richard GF, et al. Microsatellite typing sechishandiso chishandiso chekuziva kweSaccharomyces cerevisiae strains. J Clin Microbiol 2001; 39: 551-9. Wona zvisingabvumirwe.
  97. Cesaro S, Chinello P, Rossi L, Zanesco L. Saccharomyces cerevisiae fungemia mune neutropenic murwere anorapwa neSaccharomyces boulardii. Tsigira Kuchengeta Kenza 2000; 8: 504-5. Wona zvisingabvumirwe.
  98. Weber G, Adamczyk A, Freytag S. [Kurapa mburwa nekugadzirira mbiriso]. Fortschr Med 1989; 107: 563-6. Wona zvisingabvumirwe.
  99. Lewis SJ, Freedman AR. Ongorora chinyorwa: kushandiswa kwema biotherapeutic vamiririri mukudzivirira uye kurapwa kwechirwere chepamuviri. Chidimbu Pharmacol Ther 1998; 12: 807-22. Wona zvisingabvumirwe.
  100. Krammer M, Karbach U. Antidiarrheal chiito chembiriso Saccharomyces boulardii mumakonzo diki uye rakakura ura nekumutsa chloride kunwiswa. Z Gastroenterol 1993; 31: 73-7.
  101. Czerucka D, Roux I, Rampal P. Saccharomyces boulardii inhibits secretagogue-mediated adenosine 3 ', 5'-cyclic monophosphate induction mumatumbu emukati. Gastroenterol 1994; 106: 65-72. Wona zvisingabvumirwe.
  102. Elmer GW, McFarland LV, Surawicz CM, uye al. Maitiro eSaccharomyces boulardii mune anowanzoitika Clostridium difficile chirwere chevarwere. Chidimbu Pharmacol Ther 1999; 13: 1663-8. Wona zvisingabvumirwe.
  103. Fredenucci I, Chomarat M, Boucaud C, et al. Saccharomyces boulardii fungemia mumurwere anowana ultra-levure therapy. Clin Infect Dis 1998; 27: 222-3. Wona zvisingabvumirwe.
  104. Pletinex M, Legein J, Vandenplas Y. Fungemia neSaccharomyces boulardii mumusikana ane makore-1 ane chirwere chenguva refu. J Pediatr Gastroenterol Nutriti 1995; 21: 113-5. Wona zvisingabvumirwe.
  105. Buts JP, Corthier G, Delmee M. Saccharomyces boulardii yeClostridium difficile-inosanganisirwa enteropathies mune vacheche. J Pediatr Gastroenterol Nutriti 1993; 16: 419-25. Wona zvisingabvumirwe.
  106. Surawicz CM, Elmer GW, Speelman P, uye al. Kudzivirira kwehutachiona-hwakabatana manyoka neSaccharomyces boulardii: anotarisira kudzidza. Gastroenterology 1989; 96: 981-8. Wona zvisingabvumirwe.
  107. Surawicz CM, McFarland LV, Elmer G, et al. Kurapa kwekudzokororazve clostridium difficile colitis ine vancomycin uye Saccharomyces boulardii. Am J Gastroenterol 1989; 84: 1285-7. Wona zvisingabvumirwe.
  108. McFarland LV, Surawicz CM, Greenberg RN, uye al. Kudzivirira beta-lactam inosangana nemanyoka neSaccharomyces boulardii ichienzaniswa ne placebo. Am J Gastroenterol 1995; 90: 439-48. Wona zvisingabvumirwe.
  109. McFarland LV, Surawicz CM, Greenberg RN, uye al. Chiyero chisingachinjiki-chakachengetedzwa cheplacebo-Saccharomyces boulardii pamwe chete nemishonga inorwisa mabhakitiriya yeClostridium difficile chirwere. JAMA 1994; 271: 1913-8. Wona zvisingabvumirwe.
  110. Elmer GW, McFarland LV. Taura nezvekushomeka kwekurapa mhedzisiro yeSaccharomyces boulardii mukudzivirira kwemanyoka ane hukama nemishonga inorwisa mabhakitiriya muvarwere vakwegura. J Inobata 1998; 37: 307-8. Wona zvisingabvumirwe.
  111. Lewis SJ, Potts LF, Barry RE. Iko kushomeka kwekurapa mhedzisiro yeSaccharomyces boulardii mukudzivirira kwemanyoka ane hukama nemishonga inorwisa mabhakitiriya muvarwere vakwegura. J Inobata 1998; 36: 171-4. Wona zvisingabvumirwe.
  112. Bleichner G, Blehaut H, Mentec H, et al. Saccharomyces boulardii inodzivirira manyoka mune zvakanyanya kurwara chubhu-yakadyiwa varwere. Kuchengetedza Kwakasimba Med 1997; 23: 517-23. Wona zvisingabvumirwe.
  113. Castagliuolo Ini, Riegler MF, Valenick L, et al. Saccharomyces boulardii protease inhibits mhedzisiro ye clostridium difficile chepfu A uye B muvanhu colonic mucosa. Utachiona uye Immun 1999; 67: 302-7. Wona zvisingabvumirwe.
  114. Saavedra J. Probiotic uye diarrhea inotapukira. Am J Gastroenterol 2000; 95: S16-8. Wona zvisingabvumirwe.
  115. McFarland LV. Saccharomyces boulardii haisi Saccharomyces cerevisiae. Clin Infect Dis 1996; 22: 200-1. Wona zvisingabvumirwe.
  116. McCullough MJ, Clemons KV, McCusker JH, Stevens DA. Rudzi rwekuzivikanwa uye hutachiona hunhu hweSaccharomyces boulardii (nom. Inval.). J Clin Microbiol 1998; 36: 2613-7. Wona zvisingabvumirwe.
  117. Niault M, Thomas F, Prost J, et al. Fungemia nekuda kweSaccharomyces mhando mune murwere akabatwa neinopinda Saccharomyces boulardii. Clin Infect Dis 1999; 28: 930. Wona zvisingabvumirwe.
  118. Bassetti S, Frei R, Zimmerli W. Fungemia neSaccharomyces cerevisiae mushure mekurapwa neSaccharomyces boulardii. Am J Med 1998; 105: 71-2. Wona zvisingabvumirwe.
  119. Scarpignato C, Rampal P. Kudzivirira uye kurapwa kwechirwere chemufambi: A clinical pharmacological approach. Chemotherapy 1995; 41: 48-81. Wona zvisingabvumirwe.
Yakapedzisira kuongororwa - 11/10/2020

Goverana

Maitiro ekushandura bvudzi zvakanaka
Utano

Maitiro ekushandura bvudzi zvakanaka

Kuti uderedze bvudzi nenzira kwayo, unofanirwa kunge uine zvigadzirwa zvinodiwa zvemhando yepamu oro, enge hydrogen peroxide vhoriyamu makumi matatu kana makumi mana, uye neupfu hwekuchene a, nguva dz...
Kurumwa nenyoka: zviratidzo uye zvekuita
Utano

Kurumwa nenyoka: zviratidzo uye zvekuita

Chinhu chakanyanya kuko ha mu hure mekurumwa nenyoka kuchengetedza gumbo rakarumwa zvakanyanyi a ezvazvinogona, nekuti paunonyanya kufambi a huturu hunogona kuteke hera nemuviri uye huno vika panhengo...